Lyell Immunopharma (LYEL) awards director 9,250 options tied to next shareholder meeting
Rhea-AI Filing Summary
Lyell Immunopharma director Sumant Ramachandra reported an equity award and updated holdings. He received an option grant covering 9,250 shares of common stock at an exercise price of $13.22 per share, expiring on June 9, 2036.
The option vests on the earlier of the next annual stockholder meeting following June 10, 2026 (or immediately before it if his board service ends at that meeting) or the first anniversary of that date, contingent on continuous service. In addition, 10,000 shares of common stock are held indirectly by the Sumant Ramachandra Rev Trust DTD 01/24/12, where he is grantor and trustee. All share amounts reflect a 1-for-20 reverse stock split effected on May 30, 2025.
Positive
- None.
Negative
- None.
Insider Trade Summary
2 transactions reported
Mixed
2 txns
Insider
Ramachandra Sumant
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Option (right to buy) | 9,250 | $0.00 | $0.00 |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Option (right to buy) — 9,250 shares (Direct);
Common Stock — 10,000 shares (Indirect, Grantor and Trustee)
Footnotes (3)
- F1. On May 30, 2025, the Issuer effected a 1-for-20 reverse stock split of its common stock. All share and amounts reported herein reflect the reverse stock split.
- F2. Shares held by the Sumant Ramachandra Rev Trust DTD 01/24/12. The Reporting Person is grantor and trustee of the Sumant Ramachandra Rev Trust DTD 01/24/12.
- F3. The option shares shall vest on the earlier of (a) the date of the next annual meeting of the stockholders that occurs following June 10, 2026 (or the date immediately prior to such date if the Reporting Person's service as a director ends at such annual meeting due to the Reporting Person's failure to be reelected or the Reporting Person not standing for re-election); or (b) the first anniversary of June 10, 2026, subject to the Reporting Person providing continuous service through such date.
Key Figures
Option grant size: 9,250 shares
Option exercise price: $13.22 per share
Option expiration: June 9, 2036
+3 more
6 metrics
Option grant size
9,250 shares
Option (right to buy) common stock granted to director
Option exercise price
$13.22 per share
Strike price for 9,250-share option grant
Option expiration
June 9, 2036
Expiration date of granted option
Indirect common shares
10,000 shares
Common stock held by Sumant Ramachandra Rev Trust
Reverse stock split ratio
1-for-20
Reverse split of common stock on May 30, 2025
Net buy/sell direction
neutral
Transaction summary net buy/sell shares
Key Terms
1-for-20 reverse stock split, Grant, award, or other acquisition, Option (right to buy), Rev Trust, +1 more
5 terms
1-for-20 reverse stock split financial
"the Issuer effected a 1-for-20 reverse stock split of its common stock"
Grant, award, or other acquisition financial
"transaction_code_description": "Grant, award, or other acquisition""
Option (right to buy) financial
"security_title": "Option (right to buy)""
Rev Trust financial
"Shares held by the Sumant Ramachandra Rev Trust DTD 01/24/12"
continuous service financial
"subject to the Reporting Person providing continuous service through such date"
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What insider transactions did Lyell Immunopharma (LYEL) report for Sumant Ramachandra?
Lyell Immunopharma reported an option grant to director Sumant Ramachandra for 9,250 shares of common stock and listed 10,000 shares held indirectly through his revocable trust, reflecting a routine equity compensation and updated ownership disclosure.
What are the key terms of Sumant Ramachandra’s new stock option at Lyell Immunopharma (LYEL)?
The option covers 9,250 shares of Lyell common stock at an exercise price of $13.22 per share, expiring June 9, 2036. Vesting depends on future service and the next annual stockholder meeting timing.
How and when will Sumant Ramachandra’s Lyell (LYEL) stock options vest?
The options vest on the earlier of the next annual stockholder meeting after June 10, 2026, or the first anniversary of June 10, 2026, provided he continues to serve the company through that vesting date.
What type of Form 4 transaction code applies to Sumant Ramachandra’s Lyell (LYEL) option grant?
The filing uses transaction code "A," which is described as a grant, award, or other acquisition. This indicates the option was awarded as compensation rather than purchased in an open-market transaction.